-Reuters
Why Are Immunome Shares Trading Higher Today?
Immunome Inc (NASDAQ:IMNM) has submitted an Investigational New Drug (IND) application to the FDA for IMM-BCP-01, a three-antibody…
Related Posts
Kim Jong-Un’s Nuclear Tests Being Monitored ‘Very Closely’ By US
The Biden Administration is "very closely" monitoring the continued possibility of a nuclear test by Kim Jong-Un's North Korea.
Qiagen’s COVID-19 Antigen Test Gets FDA Emergency Use Approval
The FDA has granted emergency use authorization (EUA) to Qiagen N.V.’s (NYSE:QGEN) QIAreach SARS CoV-2 Antigen Test. The rapid, portable test can…
Xbox CEO Phil Spencer’s Shocking Revelation About Activision Blizzard Takeover
In an interview with IGN, Xbox CEO Phil Spencer revealed that before Microsoft Corp.'s (NASDAQ: MSFT) $68.7 billio